Source: Health Canada shortage reports · Updated Jul 9, 2026
Some Doxorubicin products are in shortage in Canada (2 of 7 reported products), while others remain available. Your pharmacy may be able to substitute an unaffected manufacturer.
A chemotherapy medication (anthracycline) used to treat many types of cancer.
Products affected
2 / 7
In shortage since
Jun 6, 2024
Reports on file
29
Talk to a pharmacist
Pharmacists can substitute an unaffected manufacturer's version, adjust strengths, and in most provinces adapt or renew a prescription on the spot.
Independent services, not affiliated with rxstat; referral fees may apply. Free options exist depending on your province. In an emergency call 911; free health advice at 811.
Shortage history
Shortage history (red bands = periods in shortage).
Reports by product
The DIN is printed on your prescription label.
Active shortage
DOXORUBICIN HYDROCHLORIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02409275 · since May 6, 2026, est. end Jul 10, 2026 · Disruption of the manufacture of the drug.
Active shortage
DOXORUBICIN HYDROCHLORIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02409275 · since Jun 6, 2024, no end estimate · Disruption of the manufacture of the drug.
Active shortage
DOXORUBICIN INJECTION, BP
2MG · SOLUTION · ACCORD HEALTHCARE INC
DIN 02381982 · since May 1, 2025, no end estimate · Requirements related to complying with good manufacturing practices.
Avoided
CAELYX
2MG · SUSPENSION · BAXTER CORPORATION
DIN 02238389 · ended Jan 7, 2026 · Disruption of the manufacture of the drug.
Resolved
DOXORUBICIN HYDROCHLORIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02409275 · ended Apr 16, 2025 · Disruption of the manufacture of the drug.
Resolved
DOXORUBICIN HYDROCHLORIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02409275 · ended Mar 19, 2025 · Disruption of the manufacture of the drug.
Resolved
TARO-DOXORUBICIN LIPOSOMAL
2MG · SUSPENSION · TARO PHARMACEUTICALS INC
DIN 02493020 · ended Oct 15, 2024 · Disruption of the manufacture of the drug.
Resolved
CAELYX
2MG · SUSPENSION · BAXTER CORPORATION
DIN 02238389 · ended Aug 29, 2024 · Delay in shipping of the drug.
Resolved
DOXORUBICIN HYDROCHLORIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02409275 · ended Oct 18, 2023 · Disruption of the manufacture of the drug.
Resolved
DOXORUBICIN HYDROCHLORIDE INJECTION
2MG · SOLUTION · TEVA CANADA LIMITED
DIN 02409275 · ended Oct 5, 2023 · Disruption of the manufacture of the drug.
Resolved
DOXORUBICIN HYDROCHLORIDE FOR INJECTION USP
50MG · POWDER FOR SOLUTION · PFIZER CANADA ULC
DIN 02194465 · ended Sep 11, 2023 · Disruption of the manufacture of the drug.
Resolved
DOXORUBICIN
2MG · SOLUTION · PFIZER CANADA ULC
DIN 02410397 · ended Sep 11, 2023 · Disruption of the manufacture of the drug.
Showing 12 of 29 reports. All reports are on file with Health Canada.
What's happening
Doxorubicin is currently affected by 2 active shortage reports filed with Health Canada by TEVA CANADA LIMITED, ACCORD HEALTHCARE INC.
The reported causes are: disruption of the manufacture of the drug; requirements related to complying with good manufacturing practices. Manufacturers must report shortages, but end-date estimates are their own projections and often move.
If your usual product is affected, a pharmacist is the fastest route to a solution: they can dispense an unaffected manufacturer's equivalent when one exists, and in most provinces can adapt doses or substitute a therapeutic alternative without a new appointment.
Doxorubicin is classified under “CYTOTOXIC ANTIBIOTICS AND RELATED SUBSTANCES” (ATC L01DB).
Recent changes
No changes recorded yet.
Common questions
What is Doxorubicin used for?
A chemotherapy medication (anthracycline) used to treat many types of cancer.
When will Doxorubicin be back in stock in Canada?
Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.
Why is Doxorubicin in shortage?
See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.
What can my pharmacist do about it?
Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.
Email alerts
Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.
Drugs in the same therapeutic class, best-supplied first. These are not automatic substitutes: only your pharmacist or prescriber can judge whether a switch makes sense for you.
Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.